What are the most commonly used muscle relaxants for acute musculoskeletal pain in adults, including typical dosing and treatment duration?

Top Muscle Relaxants for Acute Musculoskeletal Pain

For acute musculoskeletal pain in adults, cyclobenzaprine is the most commonly prescribed and best-studied muscle relaxant, though recent high-quality evidence shows skeletal muscle relaxants provide no benefit over placebo when combined with NSAIDs. 1

Critical Evidence Update

The most recent and highest-quality study (2022) analyzing data from 4 randomized trials found that none of the seven skeletal muscle relaxants tested (baclofen, metaxalone, tizanidine, diazepam, orphenadrine, methocarbamol, cyclobenzaprine) improved outcomes more than placebo when patients also received NSAIDs 1. Cyclobenzaprine specifically caused more adverse effects than placebo (p < 0.01) without providing additional benefit.

A 2025 systematic review confirmed non-benzodiazepine muscle relaxants showed increased likelihood of pain relief compared to placebo alone, but this came with significantly more central nervous system adverse effects (RR: 2.40) 2.

Most Commonly Used Agents

Based on utilization data, the dominant muscle relaxants in the U.S. are 3:

1. Cyclobenzaprine - accounts for >50% of all prescriptions
2. Baclofen - growing use
3. Tizanidine - growing use
4. Methocarbamol - growing use
5. Carisoprodol - declining use due to abuse potential

Guideline-Based Dosing (When Used)

For Older Adults 4:

• Baclofen (Lioresal): Start 5 mg up to three times daily

  • Monitor muscle weakness, urinary function, cognitive effects, sedation
  • Avoid abrupt discontinuation (CNS irritability risk)
  • Older adults rarely tolerate >30-40 mg/day

• Tizanidine (Zanaflex): Start 2 mg up to three times daily

  • Monitor muscle weakness, urinary function, cognitive effects, sedation, orthostasis
  • Multiple drug-drug interactions

• Clonazepam (Klonopin): 0.25-0.5 mg at bedtime

  • Monitor sedation, memory, complete blood count

For Low Back Pain 5:

The 2007 ACP/APS guideline notes skeletal muscle relaxants are an option for short-term relief of acute low back pain only, but all cause CNS adverse effects (primarily sedation). There is no compelling evidence that different agents differ in efficacy or safety.

Critical Warnings

Carisoprodol is metabolized to meprobamate and carries risks for abuse and overdose - its use is declining and it has been removed from European markets 5, 6.

Cyclobenzaprine is essentially identical to amitriptyline with similar anticholinergic effects 4.

Traditional "muscle relaxants" (methocarbamol, carisoprodol, chlorzoxazone, metaxalone, cyclobenzaprine) do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain 7.

Treatment Duration

Median treatment duration is 14 days, with only 4.0% using for >90 days, 1.9% for >180 days, and 1.0% for >365 days 3. These medications should be limited to short-term use only.

Clinical Algorithm

1. First-line: Topical NSAIDs with or without menthol gel 8
2. Second-line: Oral NSAIDs or acetaminophen 8
3. Consider muscle relaxants ONLY if:
   • Acute pain (<4 weeks)
   • Inadequate response to NSAIDs/acetaminophen
   • Patient can tolerate sedation
   • No contraindications (elderly, fall risk, cognitive impairment)
4. If prescribed: Use cyclobenzaprine (most studied) or tizanidine for ≤2 weeks maximum
5. Avoid: Carisoprodol (abuse potential), benzodiazepines (unless specific indication for muscle spasm with anxiety)

Key Pitfall

Approximately one-third of muscle relaxant users have no preceding musculoskeletal disorder diagnosis 3, indicating widespread off-label and potentially inappropriate use. Given the 2022 evidence showing no benefit over placebo when combined with NSAIDs 1, routine prescription of these agents cannot be justified based on efficacy data, only on historical practice patterns.